Quantcast
Channel: WN.com - Articles related to Serodus to evaluate financing options for lead programs (Serodus ASA)
Viewing all articles
Browse latest Browse all 122

Fact Sheet (Serodus ASA)

$
0
0
(Source: Serodus ASA) FOCUS Therapeutic products in Cardiovascular diseases and Diabetes Partnerships Founded 2008 Public 2013 MANAGEMENT Eva Steiness Chief Executive Officer Tore Kvam Chief Financial Officer Trygve Gulbrandsen Chief Scientific Officer Torben Skarsfeldt ABOUT SERODUS Serodus ASA (Oslo Access: SER) is a biopharmaceutical company, based in Oslo, Norway with an innovative business model. The Company has a broad pipeline of drug candidates with a primary focus on treatment of cardiovascular diseases. The Danish subsidiary Phlogo ApS has a focus on treatment of diabetes. Our products are developed exclusively through external organizations (CROs) managed by our Management group...

Viewing all articles
Browse latest Browse all 122

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>